Hikal Ltd. provides solutions related to Pharmaceuticals, Crop protection, Specialty Chemicals and Research & Technology. Hikal has five manufacturing facilities in India at Maharashtra, Gujarat, Karnataka and a Research & Technology centre at Maharashtra. Hikal CMP is 319.45.
Negative aspects of the company are high valuation (P.E = 50.2) & declining annual net profit. Positive aspects of the company are improving cash from operations, low debt, zero promoter pledge, FIIs are increasing stake, MFs are increasing stake & promoter holding increasing.
Entry in the stock can be taken after closing above 331. Targets in the stock will be 350 & 367. Long term target in the stock will be 383 & 403. Stop loss in the stock should be maintained at closing below 281.
Negative aspects of the company are high valuation (P.E = 50.2) & declining annual net profit. Positive aspects of the company are improving cash from operations, low debt, zero promoter pledge, FIIs are increasing stake, MFs are increasing stake & promoter holding increasing.
Entry in the stock can be taken after closing above 331. Targets in the stock will be 350 & 367. Long term target in the stock will be 383 & 403. Stop loss in the stock should be maintained at closing below 281.
Happy Candles Investment